论文部分内容阅读
Objective The aim of the study was to evaluate the role of ATP-based tumor chemosensitivity assay(ATP-TCA) in patients with platinum-resistant recurrent ovarian cancer (PRROC). Methods A total of 43 patients with PRROC who underwent chemotherapy based on